Go Pro
OTCMKTS:EKTAY

Elekta Q1 2027 Earnings Report

Elekta logo
$5.17 0.00 (0.00%)
As of 09/17/2026

Elekta EPS Results

Actual EPS
$0.07
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Elekta Revenue Results

Actual Revenue
$372.30 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Elekta Announcement Details

Quarter
Q1 2027
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Elekta's next earnings date is estimated for Wednesday, November 25, 2026, based on past reporting schedules.

Conference Call Resources

Elekta Earnings Headlines

Elekta AB earnings call: margins up, growth uneven
Iran War: Why Is Trump Protecting THEM?
A powerful Middle Eastern government is reportedly seeking US intelligence, targeting help, and military protection against Iran-backed forces. An anonymous source says that protection was only one side of an extraordinary bargain, with the other side potentially worth trillions of dollars to America. Addison Wiggin traced the deal linking Trump, Iran, and this government, and says the headlines look very different once you know who is involved.tc pixel
Elekta AB (publ) (EKTAY) Q1 2027 Earnings Call Transcript
See More Elekta Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elekta? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elekta and other key companies, straight to your email.

About Elekta

Elekta (OTCMKTS:EKTAY) is a Sweden-based medical technology company focused on radiation oncology and precision treatment solutions. The company develops and supplies systems used to diagnose, plan and deliver treatments for cancer and other conditions affecting the brain and nervous system.

Its product portfolio includes linear accelerators for external-beam radiotherapy, stereotactic radiosurgery systems such as Leksell Gamma Knife, brachytherapy equipment and treatment-planning, oncology information and workflow software. Elekta also provides related services, support and upgrades for healthcare providers.

Founded in 1972 by neurosurgeon Lars Leksell, Elekta has grown into an international supplier serving hospitals, clinics and cancer centers across Europe, North and South America, Asia-Pacific, the Middle East and Africa. The company is headquartered in Stockholm, Sweden, and its shares trade on Nasdaq Stockholm under the symbol “EKTA”; its American depositary shares trade over the counter under the symbol “EKTAY.”

View Elekta Profile